Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
about
Recent vaccine technology in industrial animalsCurrent Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionMechanisms of Cross-protection by Influenza Virus M2-based VaccinesUniversal influenza vaccines, a dream to be realized soon.HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F.Virus-like particles as universal influenza vaccinesImmunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceDendritic cells at the end of the millennium.Measles virus-induced suppression of immune responses.Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.HIV p24 as scaffold for presenting conformational HIV Env antigens.Ebola virus-like particles protect from lethal Ebola virus infection.Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.Effects of adjuvants on IgG subclasses elicited by virus-like particles.Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b).Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCsVirus-like particles: flexible platforms for vaccine development.Plant-derived virus-like particles as vaccinesTh2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles.Interaction of the hepatitis B core antigen and the innate immune system.Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like ParticlesVirus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.Dendritic cells and macrophages are productively infected by poliovirus.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Developments in virus-like particle-based vaccines for HIV.VLPs and particle strategies for cancer vaccines.Short communication: limited induction of IL-10 in PBMCs from HIV-infected subjects treated with HIV-VLPs.Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine.Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes.Human immunodeficiency virus-like particles activate multiple types of immune cells.Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
P2860
Q26766625-38071526-309E-41C1-8D04-371480333240Q26775082-1A97253D-84F3-4AA3-8650-C601359B8E3FQ26777740-B37AB92A-7432-4647-876B-5F68CBC87202Q30361950-4FA9F578-E66C-4C6F-8679-C1DD6479A8AFQ30418622-CA8D44DD-FCE2-4FAC-B291-789085BFFE40Q30421558-A2691650-DD7C-48DD-ADA4-60071E173CB8Q33569555-2D512FB3-2015-464D-A539-6D1E12805173Q33717736-E28D5AA9-69E8-4101-B800-12B01EBB11AEQ33762508-C0ECA7D8-2C27-4945-874E-CD6B90AE14FFQ34015320-C115DDC3-8A4F-4B46-8E53-F9818009A82FQ34208916-3977B8E6-4CA1-4D02-92B5-B139D4A36D25Q34292741-75F235F6-1292-41DF-BE46-C08201A4C44AQ34389522-45853CAC-F11D-4DB3-B855-E2196D58301CQ34792924-6483BB8D-D66E-4181-82F6-D3DA1AECB5F3Q35478282-925F5293-2913-4F76-B768-CFFFEFA4D3B8Q35635302-FF690379-3A05-455D-B99C-2CD4943D702EQ35848642-EF287E75-35E0-4D9B-A4B7-A1EC255C3EFEQ35891225-A05E2223-B918-45EB-AF18-BE4ACD37E947Q36066835-95D53F92-7DC5-4F93-B344-668689D27263Q36370281-65EA851D-D568-4BE6-8298-4CB238D3A421Q36404149-5A1E6F97-FD02-49A5-AA83-791BF7D32840Q36524099-B185CBB4-FB16-45F7-9CEA-59930D418788Q36837144-64F15119-E984-4A77-B992-6CEFA7618801Q36888029-1EC05290-94D7-4991-B00D-E209635B8D56Q37033232-5B8841B4-580A-4B77-A810-675DE5F6BA00Q37200526-71723570-6A42-44A7-A0E1-D771ED5DE378Q37516075-D787E2F6-DED3-4A4E-AFE9-8558FCA466A6Q37743908-D75E74A6-737F-46CD-A325-C34B61CF65EFQ37746786-A7F3A4AA-5645-4E4B-AAC1-506CF8EC88D6Q37951525-2EF3C061-D0AB-45FF-BAAD-A2586A1C58FCQ38081965-7A693095-7BD6-4FCA-808F-0F3110CBD7FFQ38152475-4D9F88FD-6ACA-4CCA-8F5F-86FF524A5536Q38874078-E28CDE58-9ECF-4C5C-B726-3AE379910C6BQ38879108-0A889D1B-B660-427D-B48A-F76AAD095E0BQ39427650-E525BA02-8113-4FAE-BE77-1D6EFACB3A4AQ39548736-9563E829-75AE-45CB-9865-444FDE696AE6Q40809425-5EED9555-27C0-4304-8D26-4D82192F621EQ42034526-6D301A48-F378-48EF-A0E9-EE4A6145D035Q42670565-3589E326-D9D5-444A-8CA8-076711241F2BQ42972789-B710E6EE-7E04-42E3-8855-D68EB5084D1A
P2860
Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Dendritic cells process exogen ...... CD8+ cytotoxic T lymphocytes.
@en
type
label
Dendritic cells process exogen ...... CD8+ cytotoxic T lymphocytes.
@en
prefLabel
Dendritic cells process exogen ...... CD8+ cytotoxic T lymphocytes.
@en
P2093
P356
P1476
Dendritic cells process exogen ...... CD8+ cytotoxic T lymphocytes.
@en
P2093
Bachmann MF
Rescigno M
Ricciardi-Castagnoli P
P304
P356
10.1002/EJI.1830261109
P407
P577
1996-11-01T00:00:00Z